2m 2m 2m 2m 2m 2m 2m
Theravance Bioph (TBPH)
NASDAQ
$16.96-$0.02 (-0.09%)
Price as of Jun 23, 2026 4:10 PM EDT- $1.2BMarket Cap
- 59.04%1-Year Change
- BiotechnologyIndustry
Theravance Bioph (TBPH)
$16.96-$0.02 (-0.09%)
TBPH | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.97 | ||
Change | -$0.02 (-0.12%) | ||
Open | $16.70 | ||
High | $17.10 | ||
Low | $16.64 | ||
Previous Close | $16.56 | ||
Volume | 676,266 | ||
30-Day Average Volume | 445,636 | ||
1-Week Change | 1.47% | ||
1-Month Change | 1.16% | ||
1-Year Change | 56.67% | ||
3-Year Change | 53.19% | ||
5-Year Change | -5.10% | ||
Fundamentals | |||
Shares Outstanding | 73.5M | ||
Total Assets | $472.3M | ||
Market Cap | $1.2B | ||
Enterprise Value | $928.6M | ||
Period: QTR TTM FY | |||
Revenue | $17.7M | ||
Net Income | -$4.9M | ||
Free Cash Flow | $73.3M | ||
EBIT | -$6.5M | ||
EBITDA | -$6.1M | ||
Net Working Capital | $385.9M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -152 | ||
Enterprise Value/Revenue | 52 | ||
P/B | 4 | ||
P/E | -166 | ||
PEG | 2 | ||
Price/Free Cash Flow | 17 | ||
Price/Operating Cash Flow | 17 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue